{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:22:40Z","timestamp":1790468560224,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FP7","award":["FP7-Health-2013-306029"],"award-info":[{"award-number":["FP7-Health-2013-306029"]}]},{"DOI":"10.13039\/100011264","name":"FP7-PEOPLE","doi-asserted-by":"crossref","award":["290246"],"award-info":[{"award-number":["290246"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1423-9","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T01:17:36Z","timestamp":1506734256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-172X","authenticated-orcid":false,"given":"Natalia","family":"Sherina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulda S.","family":"Hreggvidsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Israelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,30]]},"reference":[{"issue":"11","key":"1423_CR1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30(11):1205\u201313.","journal-title":"Arthritis Rheum"},{"key":"1423_CR2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62:835\u201341.","journal-title":"Ann Rheum Dis"},{"key":"1423_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, K\u00e4llberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38\u201346.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1423_CR4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","volume":"67","author":"MA Alspaugh","year":"1981","unstructured":"Alspaugh MA, Henle G, Lennette ET, Henle W. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest. 1981;67(4):1134\u201340.","journal-title":"J Clin Invest"},{"issue":"3","key":"1423_CR5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI110083","volume":"67","author":"PB Ferrell","year":"1981","unstructured":"Ferrell PB, Aitcheson CT, Pearson GR, Tan EM. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest. 1981;67(3):681\u20137.","journal-title":"J Clin Invest"},{"issue":"1","key":"1423_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar1893","volume":"8","author":"KH Costenbader","year":"2006","unstructured":"Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther. 2006;8(1):204.","journal-title":"Arthritis Res Ther"},{"issue":"14","key":"1423_CR7","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1073\/pnas.95.14.8227","volume":"95","author":"Y Takahashi","year":"1998","unstructured":"Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998;95(14):8227\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1423_CR8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.59.9.672","volume":"59","author":"JR Kerr","year":"2000","unstructured":"Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000;59:672\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1423_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2796.2006.01618.x","volume":"259","author":"C Soderberg-Naucler","year":"2006","unstructured":"Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med. 2006;259(3):219\u201346.","journal-title":"J Intern Med"},{"issue":"8426","key":"1423_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","volume":"1","author":"DG White","year":"1985","unstructured":"White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet. 1985;1(8426):419\u201321.","journal-title":"Lancet"},{"issue":"5","key":"1423_CR11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","volume":"149","author":"AD Woolf","year":"1989","unstructured":"Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989;149(5):1153\u20136.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1423_CR12","first-page":"887","volume":"33","author":"YS Chen","year":"2006","unstructured":"Chen YS, Chou PH, Li SN, Tsai WC, Lin KH, Tsai KB, et al. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J Rheumatol. 2006;33(5):887\u201391.","journal-title":"J Rheumatol"},{"issue":"4","key":"1423_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00274934","volume":"12","author":"JG Saal","year":"1992","unstructured":"Saal JG, Steidle M, Einsele H, M\u00fcller CA, Fritz P, Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int. 1992;12(4):147\u201351.","journal-title":"Rheumatol Int"},{"issue":"2","key":"1423_CR14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/08916934.2011.616557","volume":"45","author":"BL Goldstein","year":"2012","unstructured":"Goldstein BL, Chibnik LB, Karlson EW, Costenbader KH. Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women. Autoimmunity. 2012;45(2):161\u20138.","journal-title":"Autoimmunity"},{"issue":"6","key":"1423_CR15","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.34346","volume":"64","author":"M Pierer","year":"2012","unstructured":"Pierer M, Rothe K, Quandt D, Schulz A, Rossol M, Scholz R, et al. Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis. Arthritis Rheum. 2012;64(6):1740\u20139.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1423_CR16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/01.MP.0000083145.68333.9B","volume":"16","author":"Y Mehraein","year":"2003","unstructured":"Mehraein Y, Lennerz C, Ehlhardt S, Venzke T, Ojak A, Remberger K, et al. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod Pathol. 2003;16(8):811\u20137.","journal-title":"Mod Pathol"},{"issue":"7","key":"1423_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.3800119","volume":"17","author":"Y Mehraein","year":"2004","unstructured":"Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Ojak A, Zang KD. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol. 2004;17(7):781\u20139.","journal-title":"Mod Pathol"},{"issue":"5","key":"1423_CR18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.59.5.342","volume":"59","author":"HD Stahl","year":"2000","unstructured":"Stahl HD, Hubner B, Seidl B, Liebert UG, van der Heijden IM, Wilbrink B, et al. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis. 2000;59(5):342\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1423_CR19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7","volume":"42","author":"JG Saal","year":"1999","unstructured":"Saal JG, Krimmel M, Steidle M, Liebert UG, van der Heijden IM, et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 1999;42:1485\u201396.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1423_CR20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/intimm\/9.5.739","volume":"9","author":"M Takei","year":"1997","unstructured":"Takei M, Mitamura K, Fujiwara S, Horie T, Ryu J, Osaka S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol. 1997;9(5):739\u201343.","journal-title":"Int Immunol"},{"issue":"2","key":"1423_CR21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/ard.58.2.130","volume":"58","author":"C Murai","year":"1999","unstructured":"Murai C, Munakata Y, Takahashi Y, Ishii T, Shibata S, Muryoi T, et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis. 1999;58(2):130\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1423_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/art.1780310218","volume":"31","author":"BA Dijkmans","year":"1988","unstructured":"Dijkmans BA, van Elsacker-Niele AM, Salimans MM, van Albada-Kuipers GA, de Vries E, Weiland HT. Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum. 1988;31(2):279\u201381.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1423_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2004.11.011","volume":"33","author":"A Lundqvist","year":"2005","unstructured":"Lundqvist A, Isa A, Tolfvenstam T, Kvist G, Broliden K. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol. 2005;33(1):71\u20134.","journal-title":"J Clin Virol"},{"issue":"1","key":"1423_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200001)43:1<151::AID-ANR19>3.0.CO;2-I","volume":"43","author":"G Niedobitek","year":"2000","unstructured":"Niedobitek G, Lisner R, Swoboda B, Rooney N, Fassbender HG, Kirchner T, et al. Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2000;43(1):151\u20134.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1423_CR25","first-page":"1907","volume":"30","author":"D Peterlana","year":"2003","unstructured":"Peterlana D, Puccetti A, Beri R, Ricci M, Simeoni S, Borgato L, et al. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J Rheumatol. 2003;30(9):1907\u201310.","journal-title":"J Rheumatol"},{"issue":"7","key":"1423_CR26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/ard.54.7.597","volume":"54","author":"S Nikkari","year":"1995","unstructured":"Nikkari S, Roivainen A, Hannonen P, M\u00f6tt\u00f6nen T, Luukkainen R, Yli-Jama T, et al. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis. 1995;54(7):597\u2013600.","journal-title":"Ann Rheum Dis"},{"key":"1423_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"1423_CR28","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","volume":"50","author":"L Padyukov","year":"2004","unstructured":"Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50:3085\u201392.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1423_CR29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"S Saevarsdottir","year":"2011","unstructured":"Saevarsdottir S, Wedr\u00e9n S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum. 2011;63(1):26\u201336. https:\/\/doi.org\/10.1002\/art.27758 .","journal-title":"Arthritis Rheum"},{"key":"1423_CR30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","volume":"3","author":"D Hosmer","year":"1992","unstructured":"Hosmer D, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452\u20135.","journal-title":"Epidemiology"},{"issue":"3","key":"1423_CR31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0091-6749(78)90101-X","volume":"62","author":"GA Settipane","year":"1978","unstructured":"Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol. 1978;62(3):162\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1423_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1081-1206(10)61380-4","volume":"97","author":"ME Fedor","year":"2006","unstructured":"Fedor ME, Rubinstein A. Effects of long-term low-dose corticosteroid therapy on humoral immunity. Ann Allergy Asthma Immunol. 2006;97(1):113\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"1423_CR33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.39491","volume":"68","author":"N Kharlamova","year":"2016","unstructured":"Kharlamova N, Jiang X, Sherina N, Potempa B, Israelsson L, Quirke AM, et al. Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol. 2016;68(3):604\u201313. https:\/\/doi.org\/10.1002\/art.39491 .","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1423_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1128\/JCM.44.1.47-50.2006","volume":"44","author":"C Besson","year":"2006","unstructured":"Besson C, Amiel C, Le-Pendeven C, Brice P, Ferm\u00e9 C, Carde P, et al. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J Clin Microbiol. 2006;44(1):47\u201350.","journal-title":"J Clin Microbiol"},{"key":"1423_CR35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.10933","volume":"48","author":"N Balandraud","year":"2003","unstructured":"Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, Reviron D, et al. Epstein\u2013Barr virus load in the peripheral blood of patients with rheumatoid arthritis, accurate quantification using real time polymerase chain reaction. Arthritis Rheum. 2003;48:1223\u20138.","journal-title":"Arthritis Rheum"},{"key":"1423_CR36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/341947","volume":"186","author":"JR Kerr","year":"2002","unstructured":"Kerr JR, Mattey DL, Thomson W, Poulton KV, Ollier WE. Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles. J Infect Dis. 2002;186:447\u201352.","journal-title":"J Infect Dis"},{"issue":"4","key":"1423_CR37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","volume":"9","author":"C M\u00fcnz","year":"2009","unstructured":"M\u00fcnz C, L\u00fcnemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol. 2009;9(4):246\u201358. https:\/\/doi.org\/10.1038\/nri2527 .","journal-title":"Nat Rev Immunol"},{"key":"1423_CR38","doi-asserted-by":"crossref","unstructured":"Pavlovic M, Kats A, Cavallo M, Shoenfeld Y. Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus. 2010;19(7):783\u201392. PMID: 20511275.","DOI":"10.1177\/0961203310365715"},{"issue":"2","key":"1423_CR39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2008.07.005","volume":"8","author":"C Lunardi","year":"2008","unstructured":"Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev. 2008;8(2):116\u201320. https:\/\/doi.org\/10.1016\/j.autrev.2008.07.005 .","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1423_CR40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X","volume":"28","author":"C Lunardi","year":"1998","unstructured":"Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G, et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol. 1998;28(3):936\u201348.","journal-title":"Eur J Immunol"},{"issue":"1-2","key":"1423_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12026-014-8584-2","volume":"61","author":"M Cornillet","year":"2015","unstructured":"Cornillet M, Verrouil E, Cantagrel A, Serre G, Nogueira L. In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide \u03b260-74Cit which bears the immunodominant epitope of citrullinated fibrin. Immunol Res. 2015;61(1-2):117\u201325. https:\/\/doi.org\/10.1007\/s12026-014-8584-2 .","journal-title":"Immunol Res"},{"key":"1423_CR42","first-page":"647","volume":"33","author":"C Anzilotti","year":"2006","unstructured":"Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P. Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol. 2006;33:647\u201351.","journal-title":"J Rheumatol"},{"key":"1423_CR43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","volume":"54","author":"F Pratesi","year":"2006","unstructured":"Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2006;54:733\u201341.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1423_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.13652249.2011.04378.x","volume":"164","author":"F Pratesi","year":"2011","unstructured":"Pratesi F, Tommasi C, Anzilotti C, Puxeddu I, Sardano E, Di Colo G, et al. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. Clin Exp Immunol. 2011;164(3):337\u201345. https:\/\/doi.org\/ 10.1111\/j.13652249.2011.04378.x .","journal-title":"Clin Exp Immunol"},{"key":"1423_CR45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ab.2014.07.030","volume":"465","author":"G Rossi","year":"2014","unstructured":"Rossi G, Real-Fern\u00e1ndez F, Panza F, Barbetti F, Pratesi F, Rovero P, et al. Biosensor analysis of anti-citrullinated protein\/peptide antibody affinity. Anal Biochem. 2014;465:96\u2013101. https:\/\/doi.org\/10.1016\/j.ab.2014.07.030 .","journal-title":"Anal Biochem"},{"issue":"9","key":"1423_CR46","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","volume":"72","author":"C Croia","year":"2013","unstructured":"Croia C, Serafini B, Bombardieri M, Kelly S, Humby F, Severa M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. 2013;72(9):1559\u201368. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202352 .","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1423_CR47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/imm.12151","volume":"140","author":"M Brisslert","year":"2013","unstructured":"Brisslert M, Rehnberg M, Bokarewa MI. Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients. Immunology. 2013;140(4):421\u20139. https:\/\/doi.org\/10.1111\/imm.12151 .","journal-title":"Immunology"},{"issue":"12","key":"1423_CR48","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1128\/JVI.70.12.8485-8491.1996","volume":"70","author":"S Moffatt","year":"1996","unstructured":"Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol. 1996;70(12):8485\u201391.","journal-title":"J Virol"},{"key":"1423_CR49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1423-0127-16-13","volume":"16","author":"BS Tzang","year":"2009","unstructured":"Tzang BS, Chiu CC, Tsai CC, Lee YJ, Lu IJ, Shi JY, et al. Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J Biomed Sci. 2009;16:13. https:\/\/doi.org\/10.1186\/1423-0127-16-13 .","journal-title":"J Biomed Sci"},{"key":"1423_CR50","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1099\/0022-1317-82-12-3011","volume":"82","author":"JR Kerr","year":"2001","unstructured":"Kerr JR, Barah F, Mattey DL, Laing I, Hopkins SJ, Hutchinson IV, et al. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol. 2001;82:3011\u20139.","journal-title":"J Gen Virol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1423-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T14:17:35Z","timestamp":1603030655000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1423-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,30]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1423-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,30]]},"article-number":"219"}}